ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research Nasdaq:BSGM

Press/Media: Expert Comment

PeriodApr 23 2020

Media coverage

1

Media coverage

  • TitleViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research Nasdaq:BSGM
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date4/23/20
    PersonsSlobodan Paessler, John Manning, Cheng Huang